{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-103813","form_type":"8-K","ticker":"TOVX","cik":"0000894158","company_name":"Theriva Biologics, Inc.","filed_at":"2024-09-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.212980+00:00","generated_at":"2026-05-31T01:02:39.834686+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Theriva Biologics closes $2.5M public offering of shares and warrants","bullets":["Aggregate gross proceeds of approximately $2.5 million from offering of common shares and warrants.","Pricing at $1.75 per share and accompanying warrant; warrants exercisable at $2.00 per share for five years.","Post-offering outstanding shares: 2,272,462; proceeds for working capital, R&D, and manufacturing scale-up.","A.G.P./Alliance Global Partners served as placement agent with 7% fee plus expense reimbursement."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-103813","json":"https://secwatch.observer/filing/0001104659-24-103813.json","markdown":"https://secwatch.observer/filing/0001104659-24-103813.md","text":"https://secwatch.observer/filing/0001104659-24-103813.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/894158/000110465924103813/0001104659-24-103813-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/894158/000110465924103813/tm2425109d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T01:02:39.834686+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}